Thomas R. Cellitti - 15 May 2023 Form 4/A - Amendment Insider Report for CORE MOLDING TECHNOLOGIES INC (CMT)

Role
Director
Signature
/s/ John P. Zimmer, as attorney-in-fact
Issuer symbol
CMT
Transactions as of
15 May 2023
Net transactions value
-$421,822
Form type
4/A - Amendment
Filing time
26 May 2023, 08:24:08 UTC
Date Of Original Report
16 May 2023
Previous filing
12 May 2023
Next filing
15 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMT Common Stock Sale $421,822 -21,643 -17% $19.49 105,943 15 May 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The date in Column 2 is the earliest transaction date. These shares were purchased over multiple days, 05/15/2023 and 05/16/2023, inclusive. The reporting person undertakes to provide to Core Molding Technologies, Inc. or the staff of the Securities Exchange Commission, upon request.
F2 This amendment is to correct the quantity for the reported transaction, which was incorrectly stated in the initial form 4 filed on May 16, 2023. The quantity sold is 21,643 shares instead of 21,463 as initially stated.
F3 The price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from 18.75 to 20.30, inclusive. The reporting person undertakes to provide to Core Molding Technologies, Inc. or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.